Search

Search Constraints

You searched for: Author/Creator Benettaib, Bouchra

Search Results

1. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children. (March 2019)

2. Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols. (March 2019)

3. Outcomes in RBC transfusion‐dependent patients with Low‐/Intermediate‐1‐risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS‐004 study. (9th June 2014)

4. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. (September 2020)

5. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. (September 2020)

6. Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia. Issue 7 (10th March 2021)